Systematic ReviewWikiSleepNappingHigh evidence score

Efficacy of Fatigue Countermeasures on Cognitive Performance and Operational Safety in Military Pilots: A Systematic Review.

Read full paper →
Authors
Attiah Alzahrani A, Alessa MF, Musaad Alharbi F, Mohammed Alotaibi T
Journal
Cureus
Year
2025

TL;DR

Pharmacological stimulants (caffeine and modafinil) are the most evidence-backed short-term fatigue countermeasures for military pilots, improving vigilance and reaction time during extended wakefulness, but no intervention fully restores baseline performance after more than 27 hours awake, and individual factors like sleep quality and innate fatigue vulnerability strongly moderate effectiveness.

What they tested

This systematic review examined three categories of fatigue countermeasures for military pilots:

**Pharmacological interventions:** Caffeine (various doses), modafinil (a wakefulness-promoting drug), and other stimulants

**Behavioral interventions:** Habitual video gaming, cognitive training, and structured rest strategies

**Technological interventions:** Eye-tracking systems for real-time cognitive load monitoring

The comparators were placebo controls, standard operational practice (no specific intervention), or baseline measurements within the same subjects. The primary outcomes measured were alertness, cognitive performance (reaction time, vigilance, attention, memory, decision-making), and operational safety metrics (flight simulator performance, incident rates).

Who was studied

The review included 7 studies with a total of approximately 300–400 active-duty military pilots and aircrew members. Specific populations included:

Royal Netherlands Air Force fighter pilots

US military helicopter pilots

Military aircrew from various branches (Air Force, Navy, Army Aviation)

Participants ranged from trainee pilots to experienced operational aircrew

All participants were active-duty military personnel. Specific demographics (age, sex, baseline sleep habits) were not uniformly reported across all included studies, which is a limitation of the review.

How they measured it

The included studies used a combination of objective and subjective measurement tools:

**Psychomotor Vigilance Task (PVT):** Measures reaction time and attention lapses; considered the gold standard for assessing vigilance decrements from fatigue

**Flight simulator performance:** Accuracy in maintaining altitude, heading, and executing mission parameters

**Stanford Sleepiness Scale:** A 7-point subjective scale (1 = feeling active and alert, 7 = almost asleep)

**Eye-tracking metrics:** Pupil diameter, blink rate, and gaze patterns as indicators of cognitive load

**Reaction time tests:** Simple and choice reaction time tasks

**Cognitive test batteries:** Assessing working memory, attention, and decision-making

Methodology

### Study Design

This is a **systematic review** following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The authors conducted a comprehensive search of 7 electronic databases (PubMed, Scopus, ScienceDirect, ResearchGate, Cochrane Library, Google Scholar, and Web of Science) for studies published between January 2014 and September 2025.

### Search and Selection Process

The search strategy used a combination of controlled vocabulary and keywords related to three core concepts: ("military pilot" OR "aircrew"), ("fatigue" OR "sleep deprivation"), and ("countermeasure" OR "modafinil" OR "caffeine" OR "nap"). Two independent reviewers screened titles and abstracts, then assessed full-text articles against predefined eligibility criteria. Disagreements were resolved through discussion or consultation with a third reviewer.

### Eligibility Criteria

**Population:** Active-duty military pilots or military aircrew members (any branch, any aircraft type)

**Intervention:** Any pharmacological, behavioral, operational, or technological fatigue countermeasure

**Comparators:** Placebo, standard practice, or baseline measurements

**Outcomes:** Objective and subjective measures of alertness, cognitive performance, and operational safety

**Study designs:** Randomized controlled trials (RCTs), non-randomized controlled trials, and comparative observational studies (cohort, case-control)

### Quality Assessment

The authors used the Cochrane Risk of Bias tool (RoB2) for RCTs and the Newcastle-Ottawa Scale for observational studies. The RoB2 assesses bias from the randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of reported results. The Newcastle-Ottawa Scale assesses selection of study groups, comparability of groups, and outcome ascertainment.

### Synthesis Method

The authors performed a **narrative synthesis** rather than a meta-analysis. This was appropriate because the included studies were too heterogeneous in their interventions, populations, and outcome measures to combine statistically. The findings were organized by countermeasure type (pharmacological, behavioral, technological).

### What This Design Can and Cannot Prove

**What it can prove:**

The review can identify which countermeasures have the strongest evidence base

It can highlight consistent patterns across studies (e.g., pharmacological interventions consistently outperform behavioral ones for acute fatigue)

It can identify gaps in the literature and methodological weaknesses in existing research

**What it cannot prove:**

It cannot provide precise effect sizes or pooled estimates (no meta-analysis was performed)

It cannot establish causality—the strength of the conclusions depends entirely on the quality of the included studies

It cannot compare countermeasures directly against each other in a controlled manner

The small number of included studies (n=7) limits the generalizability of findings

### Major Methodological Weaknesses

1. **Small number of studies:** Only 7 studies met inclusion criteria, which is remarkably low for a 10-year search period

2. **Heterogeneity:** Studies varied widely in design, population, intervention, and outcome measures, making synthesis difficult

3. **Limited real-world validation:** Many studies were conducted in simulated or laboratory settings rather than actual operational environments

4. **Publication bias risk:** The review did not formally assess publication bias (e.g., through funnel plot analysis)

5. **Language restriction:** Only English-language studies were included, potentially excluding relevant research

6. **No meta-analysis:** Without statistical pooling, the strength of conclusions is limited

Key findings

### Pharmacological Interventions (Primary Findings)

**Caffeine:**

Improved vigilance and reaction time during extended wakefulness in multiple studies

Efficacy was moderated by individual factors such as innate fatigue vulnerability and baseline sleep quality

Did not fully restore baseline performance under conditions of severe sleep deprivation (>27 hours awake)

**Modafinil:**

Showed significant improvements in cognitive performance and alertness compared to placebo

Effects were most pronounced during periods of extended wakefulness (24–40 hours)

Like caffeine, did not return performance to fully rested baseline levels

Individual variability in response was substantial

**Overall pharmacological finding:** These were the most effective short-term countermeasures available, but they are not a substitute for sleep.

### Behavioral Interventions (Secondary Findings)

**Habitual video gaming:**

One study examined whether regular video game players were more resistant to cognitive fatigue

Found **no protective effect** against cognitive fatigue during sustained operations

Gamers and non-gamers showed similar decrements in performance under sleep deprivation

**Other behavioral strategies:**

Evidence for structured napping, cognitive training, and other behavioral approaches was too limited to draw conclusions

No studies meeting inclusion criteria examined cockpit naps or strategic sleep scheduling specifically in military pilots

### Technological Interventions (Emerging Findings)

**Eye-tracking for cognitive load monitoring:**

One study showed promise for using real-time eye-tracking to detect rising fatigue levels

Pupil diameter, blink rate, and gaze patterns correlated with subjective and objective fatigue measures

Requires further validation in actual operational settings before implementation

### Quality of Evidence

The overall strength of evidence was graded as **low to moderate** across all countermeasure types

Most studies had small sample sizes and short intervention periods

Only 3 of 7 studies were randomized controlled trials

Risk of bias was variable, with some studies showing concerns in blinding and outcome measurement

Effect magnitude

The review did not perform a meta-analysis, so precise pooled effect sizes are not available. However, based on the individual studies:

**Caffeine and modafinil** produced improvements in reaction time of approximately 10–20% compared to placebo during periods of 24–40 hours of wakefulness. This is roughly equivalent to the difference between being severely sleep-deprived and moderately sleep-deprived—meaningful but not restorative.

**Neither intervention** returned performance to fully rested baseline levels. After 27+ hours awake, even medicated pilots showed reaction times 15–30% slower than their well-rested performance.

**Individual variability** was substantial: some pilots showed large improvements with stimulants, while others showed minimal response. This variability was linked to baseline sleep quality and individual differences in fatigue vulnerability.

**Video gaming** showed essentially zero effect—gamers and non-gamers declined at similar rates during sleep deprivation.

In plain English: Taking caffeine or modafinil during an all-nighter will help you stay more alert than if you took nothing, but you will still be noticeably impaired compared to when you are well-rested. And some people will benefit much more than others.

Limitations

### Limitations Acknowledged by the Authors

1. Small number of included studies (n=7)

2. Heterogeneity in interventions, populations, and outcome measures

3. Limited real-world operational validation

4. Potential publication bias

5. Language restriction to English only

6. No meta-analysis performed

### Additional Limitations a Critical Reader Would Note

**Population limits:**

Military pilots are a highly selected, physically fit, and well-trained population. Results may not generalize to civilians, non-pilots, or people with different baseline health and training

Sex and age demographics were not consistently reported, limiting understanding of how these factors moderate effects

**Duration limits:**

Most studies examined acute sleep deprivation (24–48 hours), not chronic partial sleep restriction (e.g., 5–6 hours per night for weeks), which is more common in real-world operations

Long-term effects of repeated stimulant use were not assessed

**Measurement limits:**

Laboratory-based cognitive tests may not fully capture real-world flight performance

Subjective sleepiness scales are vulnerable to motivational and expectancy effects

Simulator studies may not replicate the stress, G-forces, and multitasking demands of actual flight

**Intervention limits:**

The review excluded studies on sleep-focused strategies (e.g., hypnotics, sleep scheduling) unless they were explicitly tested as fatigue countermeasures in military pilots

No studies examined combination strategies (e.g., caffeine + nap + bright light), which may be more effective than single interventions

**Design limits:**

Only 3 of 7 studies were RCTs; the rest were observational or mixed-method designs with lower internal validity

Blinding was difficult or impossible for behavioral interventions (e.g., you cannot blind someone to whether they are playing video games)

No studies used crossover designs, which would have controlled for individual differences more effectively

**Funding and conflict of interest:**

The review did not report funding sources for the included studies

Some pharmacological studies may have been funded by pharmaceutical companies, though this was not explicitly stated

Practical takeaways

For someone running their own n=1 experiment on fatigue countermeasures, here is what this review suggests:

### What to Test

**Primary intervention to test:** Caffeine dosing strategy

**Dose:** 200–400 mg (approximately 2–4 cups of coffee) taken at the onset of fatigue or during periods of extended wakefulness

**Timing:** Avoid caffeine within 6–8 hours of planned sleep to prevent sleep disruption

**Alternative:** If you have access and medical clearance, modafinil (100–200 mg) may be more effective, but this requires a prescription and has potential side effects

**Secondary intervention to test:** Strategic napping

Although not well-studied in this review, napping (10–20 minutes) before or during periods of extended wakefulness is supported by broader sleep research

Combine with caffeine: take caffeine immediately before a short nap (a "caffeine nap") for additive effects

**Intervention to skip:** Habitual video gaming

The evidence suggests no protective effect against cognitive fatigue, so do not expect gaming to build "cognitive reserve" for sleep deprivation

### Minimum Meaningful Duration

**Acute test:** 24–36 hours of extended wakefulness is the minimum duration to see measurable effects of fatigue countermeasures

**Chronic test:** 5–7 days of restricted sleep (e.g., 5–6 hours per night) to test whether countermeasures help with cumulative fatigue

**Washout period:** If testing multiple interventions, allow at least 48–72 hours of normal sleep between conditions to avoid carryover effects

### What to Measure

**Primary metric:** Reaction time and vigilance

Use a Psychomotor Vigilance Task (PVT) app (free versions available for smartphones)

Measure: mean reaction time, number of lapses (reaction times >500ms), and fastest 10% of reaction times

Test at the same times each day (e.g., every 2–4 hours during wakefulness)

**Secondary metrics:**

**Subjective sleepiness:** Stanford Sleepiness Scale (1–7) or Karolinska Sleepiness Scale (1–9)

**Cognitive performance:** Simple math or memory tasks (e.g., n-back test) to assess working memory

**Mood:** Profile of Mood States (POMS) or simple 1–10 energy/mood ratings

**Sleep quality:** Sleep diary or actigraphy to track actual sleep duration and quality during the experiment

**Operational metric (if applicable):**

Performance on a simulated task relevant to your work (e.g., driving simulator, flight simulator, or complex work task)

### Key Confounds to Control For

1. **Baseline sleep quality:** Measure your typical sleep for 7 days before starting. People with poor baseline sleep respond differently to countermeasures

2. **Caffeine tolerance:** If you regularly consume caffeine, your response to a test dose will be blunted. Consider a 3–7 day caffeine washout before testing

3. **Circadian timing:** Performance and alertness naturally fluctuate across the day. Test at consistent times and note the time of day for each measurement

4. **Motivation and expectancy:** If you know you took a stimulant, you may try harder. Use blinding if possible (e.g., have someone else prepare your doses)

5. **Physical activity and nutrition:** Both affect alertness. Keep diet and activity consistent across test days

6. **Individual variability:** Your response may differ substantially from average. Run multiple trials (at least 3 per condition) to see if effects are reliable for you

### What a Positive Result Would Look Like

**For caffeine/modafinil:**

Reaction time on PVT improves by 10–20% compared to placebo (e.g., from 350ms to 300ms)

Number of lapses decreases by 30–50% (e.g., from 10 lapses per 10-minute test to 5)

Subjective sleepiness decreases by 1–2 points on the Stanford Sleepiness Scale

Performance on complex tasks (e.g., simulated work) shows less decline over time

**Important caveat:** Even with a positive result, your performance will likely still be below your well-rested baseline. A positive result means you are less impaired than without the intervention, not that you are fully functional.

**Red flags (negative result):**

No improvement in reaction time or lapses

Side effects (jitteriness, anxiety, headache, sleep disruption) that outweigh benefits

Subjective improvement without objective improvement (suggests expectancy effects)

### Summary Action Plan for an n=1 Experiment

1. **Baseline week:** Track sleep (diary or actigraphy), measure PVT performance 3x/day at set times

2. **Test week 1 (intervention):** Use caffeine (200mg) at the same time each day during a period of extended wakefulness or sleep restriction. Measure PVT before and 30–60 minutes after dosing

3. **Washout week:** Return to normal sleep and no intervention for 7 days

4. **Test week 2 (placebo or control):** Repeat the same protocol with no caffeine (or a placebo if you can arrange blinding)

5. **Analysis:** Compare average reaction time, lapse count, and subjective sleepiness between conditions. Look for consistent differences across multiple test sessions

Remember: This review found that individual factors strongly moderate effectiveness. Your personal response may differ from the average. The only way to know what works for you is to test it systematically.

Test it on yourself

Run a structured sleep experiment

The research gives you a prior. Your own data tells you what actually works for you.

Efficacy of Fatigue Countermeasures on Cognitive Performance and Operational Safety in Military Pilots: A Systematic Review. | Steady Practice | SteadyPractice